This page does not exist in your selected language. Your preference was saved and you will be notified once a page can be viewed in your language.
This page is also available in your prefered language. Switch to that version.
PDF | 5.0 MB
This article critically examines the safety of single-use (SU) systems in cell and gene therapy applications, focusing on the low risk posed by process equipment-related leachables (PERLs). It demonstrates how modeling can predict PERL concentrations and their interaction with therapeutic cells, and uses cell-painting assays to assess the impact of extractables on human cells, showing how SU systems can support safety standards in these therapies.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now